Samsung adds another Lucentis interchangeable biosimilar to the mix
The FDA earlier this month signed off on another interchangeable biosimilar, one of just a handful to date, this time to Samsung Bioepis for its …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
